Daybreak

Pharmeasy, once the highest-valued Indian healthcare startup, is planning to raise money in a new round of funding at a 90% markdown from its previous valuation.

From $5.6 billion to $500 million. 

All because Pharmeasy had to take another debt to pay off its previous debt. The second time though, interest rates were not zero.

What's going on?

Tune in.

Recommendation

Byju’s is looking like a hedge fund

The tail of acquisitions wagging India’s funding dog

Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.


Join The Ken as a Podcast Producer and work with India's most ambitious storytellers! We’re creating a podcast about India’s biggest companies, with each episode backed by weeks of deep research. You’ll lead the workflows that turn that research into exceptional narratives and bring the show to listeners around the world. Join us to help shape something exceptional. Check out the details and apply here. 

What is Daybreak?

Business news is complex and overwhelming. It doesn’t have to be. Every day of the week, from Monday to Friday, Daybreak tells one business story that’s significant, simple and powerful.

Hosted from The Ken’s newsroom by Snigdha Sharma and Rachel Varghese, Daybreak relies on years of original reporting and analysis by some of India’s most experienced and talented business journalists.